-
公开(公告)号：US20140315847A1
公开(公告)日：2014-10-23
申请号：US14210903
申请日：2014-03-14
发明人： Rhonda Peck , Bhavin Shah , Umesh H. Patel , Krista Gearhart , Steven Charlebois , Keith Milner , Eric J. Rodenberg
CPC分类号： A61L31/146 , A61L27/3633 , A61L27/54 , A61L27/56 , A61L31/005 , A61L31/16 , A61L2300/406 , A61L2300/414
摘要： The present invention provides, in certain aspects, medical graft products that incorporate multiple drug depots in and/or on the products. One such product is a sheet graft construct, for example for tissue support that includes a sheet graft material with a plurality of drug depots. The drug depots can be hardened deposits formed directly onto the sheet graft material and/or can be capable of eluting a drug for a minimum of 72 hours.
摘要翻译： 在某些方面，本发明提供在产品中和/或上并入多个药物贮库的医用移植产品。 一种这样的产品是片状移植物构建体，例如用于组织支撑物，其包括具有多个药物贮库的片材移植材料。 药物贮库可以是直接形成在片状接枝材料上的硬化沉积物和/或能够将药物洗脱至少72小时。
-
公开(公告)号：US11065368B2
公开(公告)日：2021-07-20
申请号：US14210903
申请日：2014-03-14
发明人： Rhonda Peck , Bhavin Shah , Umesh H. Patel , Krista Gearhart , Steven Charlebois , Keith Milner , Eric J. Rodenberg
摘要： The present invention provides, in certain aspects, medical graft products that incorporate multiple drug depots in and/or on the products. One such product is a sheet graft construct, for example for tissue support that includes a sheet graft material with a plurality of drug depots. The drug depots can be hardened deposits formed directly onto the sheet graft material and/or can be capable of eluting a drug for a minimum of 72 hours.
-
公开(公告)号：US11746443B1
公开(公告)日：2023-09-05
申请号：US16893777
申请日：2020-06-05
发明人： Bhavin Shah , Benjamin Kline , Rhonda Peck
CPC分类号： D01F6/625 , A61L27/18 , A61L29/06 , A61L31/06 , D02J1/20 , D10B2331/041 , D10B2401/061 , D10B2509/00
摘要： A polymeric material fiber includes a polymeric material which is a homopolymer of caprolactone or a copolymer of at least 90% by weight of caprolactone and one or more additional monomers. An implantable mesh includes this fiber alone or combined with one or more additional fiber materials. Methods for treating patients involve implanting the fiber material, for example incorporated in a mesh.
-
公开(公告)号：US20240068131A1
公开(公告)日：2024-02-29
申请号：US18459805
申请日：2023-09-01
CPC分类号： D01F6/625 , A61L27/18 , A61L29/06 , A61L31/06 , D02J1/20 , D10B2331/041 , D10B2401/061 , D10B2509/00
摘要： A polymeric material fiber includes a polymeric material which is a homopolymer of caprolactone or a copolymer of at least 90% by weight of caprolactone and one or more additional monomers. An implantable mesh includes this fiber alone or combined with one or more additional fiber materials. Methods for treating patients involve implanting the fiber material, for example incorporated in a mesh.
-
公开(公告)号：US20210308342A1
公开(公告)日：2021-10-07
申请号：US17353969
申请日：2021-06-22
发明人： Rhonda Peck , Bhavin B. Shah , Umesh H. Patel , Krista Gearhart , Steven Charlebois , Keith Milner , Eric J. Rodenberg
摘要： The present invention provides, in certain aspects, medical graft products that incorporate multiple drug depots in and/or on the products. One such product is a sheet graft construct, for example for tissue support that includes a sheet graft material with a plurality of drug depots. The drug depots can be hardened deposits formed directly onto the sheet graft material and/or can be capable of eluting a drug for a minimum of 72 hours.
-
-
-
-
搜索结果
5 条记录 (耗时 0.015 秒)
